Company: LNAI
Filing Date: 2025-02-19
Form Type: 10-Q/A
Source: 0001731122-25-000250
Chunk: 8

Company: Lunai Bioworks Inc.
Filing Date: 2025-02-19
Form: 10-Q/A
Chunk 8
---
 |             |   |
| Foreign currency translation, net of taxes |     |                            |   1,061,201 |   |     |      | (2,110     | ) |     |                           |   1,063,852 |   |     |      | (1,949      | ) |
| Comprehensive Loss                         |     |                          $ | (57,928,869 | ) |     |    $ | (4,330,406 | ) |     |                         $ | (71,630,367 | ) |     |    $ | (16,487,753 | ) |

<div align='center'>See accompanying notes to the unaudited condensed consolidated
financial statements.

4

RENOVARO INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(UNAUDITED)</div>

|                                                                                          |     | 

# of Series A Preferred Shares |          |   |     | Series A Preferred Shares Amount |     |   |     | # of common Shares |             |     | Common Shares |        |     | Additional Paid-In Capital |             |   |     | Accumulated Deficit |              |   |     | Accumulated Other Comprehensive Income |           |   |     | Total |             |   |
|:-----------------------------------------------------------------------------------------|:----|:-------------------------------|---------:|:--|:----|:---------------------------------|----:|:--|:----|:-------------------|------------:|:----|:--------------|-------:|:----|:---------------------------|------------:|:--|:----|:--------------------|:-------------|:--|:----|:---------------------------------------|----------:|:--|:----|:------|------------:|:--|
| June 30, 2023                                                                            |     |                                |        — |   |     |                                  |   — |   |     |                    |  63,698,144 |     | $             |  6,371 |     | $                          | 290,554,875 |   |     | $                   | (244,029,253 | ) |     | $                                      |   (29,882 | ) |     | $     |  46,502,111 |   |
| Issuance of preferred stock and warrants in private placement                            |     |                                |  280,505 |   |     |                                  |